Treatment with the phosphodiesterase type 4 inhibitor rolipram fails to inhibit blood brain barrier disruption in MS

Rolipram, a prototypic phosphodiesterase-4 inhibitor is highly effective in suppressing Th1 autoimmunity in multiple animal models, including experimental autoimmune encephalomyelitis (EAE). Additionally, Rolipram has been extensively studied as a potential neuroprotective agent. Based on its anti-i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bielekova, Bibiana, Richert, Nancy, Howard, Thomas, Packer, Amy N., Blevins, Gregg, Ohayon, Joan, McFarland, Henry F., Stürzebecher, Claus-Steffen, Martin, Roland
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2009
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3085182/
https://ncbi.nlm.nih.gov/pubmed/19776093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458509345903
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak